| Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH |
2014-08-06 |
| Amptek–AMETEK: investment, 201408 acquisition of Amptek Inc |
2014-08-05 |
| Prosarix–Evolva: investment, 201408 acquisition in shares with 1.2m Evolva shares upfront + 2m shares milestones |
2014-08-04 |
| Santaris Pharma–Roche: investment, 201408 acquisition $250m upfront cash + $200m milestones |
2014-08-04 |
| i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology |
2014-08-01 |
| i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF |
2014-08-01 |
| i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg |
2014-08-01 |
| Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels |
2014-08-01 |
| Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels |
2014-08-01 |
| IBL International–Tecan: investment, 201407 acquisition €29m in cash |
2014-07-30 |
| Riboxx–SEVERAL: investment, 201407–201501 crowdfunding €1m via Seedmatch |
2014-07-30 |
| Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) |
2014-07-29 |
| Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights |
2014-07-29 |
| BIA Separations–Showa Denko: investment, 201407 existent Showa Denko is co-owner of BIO Separations GmbH |
2014-07-29 |
| Showa Denko–BIA Separations: LC columns, 201407– collab expansion Showa Denko takes over BIA sales in Asia-Pacific region |
2014-07-29 |
| Boehringer–Hikma: investment, 201407– acquisition of US generic injectiables business Bedford Laboratories by Hikma from BI |
2014-07-28 |
| Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties |
2014-07-28 |
| Butalco–Lesaffre: investment, 201407 acquisition |
2014-07-23 |
| Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system |
2014-07-22 |
| InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen |
2014-07-17 |
| LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding |
2014-07-17 |
| Metrohm–Waters: chromatography s/w, 201407– collab product integration Empower CDS now can control Metrohm IC systems |
2014-07-17 |
| Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd |
2014-07-17 |
| Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures |
2014-07-16 |
| Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al |
2014-07-16 |
| Siemens–Danaher: investment, 201407– acquisition Siemens Healthcare Diagnostics' Clinical Microbiology Business by Beckman Coulter |
2014-07-16 |
| Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion |
2014-07-15 |
| Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH |
2014-07-15 |
| Geisinger–Indivumed: tissue bank, 201407– collab to create cancer research biobanks at Geisinger + Indivumed |
2014-07-15 |
| Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia |
2014-07-14 |
| Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors |
2014-07-10 |
| International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–EuropaBio: biotechnology, 201407 EuropaBio is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–Swiss Biotech Association: biotechnology, 201407 SBA is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA |
2014-07-10 |
| InSphero–Protea Biosciences: tissue analysis, 201407– collab product integration LAESI molecular MS imaging with 3D InSight microtissues |
2014-07-09 |
| Sophia Genetics–Endeavour Vision: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom |
2014-07-08 |
| Sophia Genetics–Invoke Capital: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom |
2014-07-08 |
| Sophia Genetics–SEVERAL: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom |
2014-07-08 |
| Analyticon Discovery–BRAIN: investment, 201407 acquisition of majority share €na by BRAIN w remaining shares held by management + key personnel |
2014-07-03 |
| Miacom Diagnostics–Fosun: investment, 201407 acquisition of 37% share by Shanghai Fosun Pharmaceutical Group |
2014-07-02 |
| Seragon Pharmaceuticals–Roche: investment, 201407– acquisition $725m upfront cash + $1b milestones by Genentech ANNOUNCED |
2014-07-02 |
| AbbVie–Apogenix: TRAIL receptor agonists, 201407 aquisition of ww rights to all TRAIL receptor agonists of Apogenix by AbbVie |
2014-07-01 |
| GeneWeave–SEVERAL: investment, 201407 financing round Series B $12m from Decheng Capital + Claremont Creek Ventures + XSeed Capital |
2014-07-01 |
| Qiagen–Altano Diagnostics: real-time PCR test, 201412– distribution ww of RealStar Ebolavirus RT-PCR Kit 1.0 by Qiagen |
2014-07-01 |
| Qiagen–Altano Diagnostics: real-time PCR test, 2014Q3– distribution of RealStar Filovirus RT-PCR Kit by Qiagen outside US |
2014-07-01 |
| Santhera–SEVERAL: investment, 201407–201408 sale CHF13.4m of 200k treasury common shares at CHF66.85/share |
2014-07-01 |
| RedHill Biopharma–Wilex: upamostat, 201406– license excl ww for Mesupron outside Greater China $1m upfront + royalties of up to 30% on net revenues |
2014-06-30 |
| Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds |
2014-06-27 |
| GW Pharmaceuticals–SEVERAL: investment, 201406 public offering $126.3m with 1.455m ADSs at $86.83/ADS at Nasdaq |
2014-06-25 |
| Merck (DE)–Mersana: ADC technology, 201406– collab €na using Flemixer technology to develop ADCs |
2014-06-24 |
| Agilent–Bruker Corp: chromatography data system, 201406 collab product integration exchange of instrument drivers for Compass CDS + OpenLab CDS |
2014-06-23 |
| Argenx–SEVERAL: investment, 201406–201408 IPO €41.8m 4.7m+0.2m shares at €8.5/shares at Euronext Brussels |
2014-06-23 |
| Bayer–Dimension Therapeutics: gene therapy, 201406– collab €20m upfront + $232m milestones + royalties developm of Hemophilia A gene therapy |
2014-06-23 |
| CytoTools–Instinctif Partners: public relations, 201406 service existent by Instinctif Partners |
2014-06-23 |
| CytoTools–SEVERAL: investment, 201406 capital increase €1.7m of CytoPharma GmbH incl €0.3m from >40% owner CytoTools |
2014-06-23 |
| Definiens–SEVERAL: investment, 201406 financing round €15m led by Wellington Partners + co-led by Gilde Healthcare |
2014-06-23 |
| Dimension Therapeutics–SEVERAL: investment, 201406 financing round $30m from OrbiMed + Fidelity Biosciences |
2014-06-23 |
| Paion–SEVERAL: investment, 201406–201407 capital increase €46.26m placement of 18.5m new shares €2.5/share |
2014-06-18 |
| Bruker Corp–Max Planck: mass spectrometry s/w, 201406 collab MaxQuant proteomics s/w supporting Bruker UHR-QTOF MS with MPI Matthias Mann group |
2014-06-16 |
| Florida State Univ–Bruker Corp: FTMS magnet, 201406 supply of 21 Tesla magnet for FTC-ICR MS co-designed by NHMFL |
2014-06-16 |
| Thermo Fisher–Excellims: ion mobility spectrometer, 201406 collab co-developm + product integration of MA3100 HPIMS with Orbitrap-based MS systems |
2014-06-16 |
| Univ Copenhagen–Thermo Fisher: mass spectrometer, 201406 supply existent Jesper Olsen at NNF CPR has been early-access user of Q Exactive HF system |
2014-06-16 |
| Covidien–Medtronic: investment, 201406– acquisition $42.9b in cash + shares ANNOUNCED |
2014-06-15 |
| Merck (DE)–MorphoSys: antibody cancer drug, 201406– strategic collab €na using Ylanthia to identify MAbs against immune checkpoints in cancer |
2014-06-12 |
| Genkyotex–Halsin Partners: public relations, 201406 service existent by Halsin Partners |
2014-06-11 |
| Idenix–Merck (US): investment, 201406– acquisition $3.85b cash tender offer $24.5/share ANNOUNCED |
2014-06-09 |
| 4SC–Strüngmann Group: credit, 201406–201612 loan of up to €10m w 8% interest from Santo Holding (Deutschland) GmbH |
2014-06-05 |
| Genia–Roche: investment, 201406 acquisition $125m in cash + $225m milestones ANNOUNCED |
2014-06-02 |
| B Braun–CeGaT: personalised medicine, 201406 collab establishment of B Braun CeGaT LLC in Pennsylvania |
2014-06-01 |
| Saab–Bruker Corp: analytical instruments, 201406–201511 supply chemical detectors for Saab AWR system delivered to client in Kuwait |
2014-06-01 |
| Luphos–AMETEK: investment, 201405 acquisition of Luphos GmbH by AMETEK |
2014-05-30 |
| Bayer–Argenx: antibody technology, 201405– collab use of SIMPLE Antibody platform to discover + develop therap antibodies against Bayer targets |
2014-05-28 |
| Euprotec–Evotec: investment, 201405 acquisition 100% for £1.9m cash upfront + deferred business performace-based payment |
2014-05-28 |
| GSK–Genedata: Genedata Biologics, 201405– supply + collab GSK Biopharm RnD |
2014-05-28 |
| Roche–Stratos: DNA sequencing technology, 201405– collab r+d of SBX technology incl strategic investment by Roche |
2014-05-26 |
| Stratos–Roche: investment, 201405 strategic investment in Stratos Genomics in connection with collab on SBX technology |
2014-05-26 |
| Neuway Pharma–SEVERAL: investment, 201405 financing round Series A €2.7m led by Wellington Partners |
2014-05-25 |
| Neuway Pharma–Wellington Partners: investment, 201405 financing round Series A totalling €2.7m led by Wellington Partners |
2014-05-25 |
| Affimed–SEVERAL: investment, 201405–201409 IPO $56m+$8.4m offering 8m+1.2m common shares $7/share at Nasdaq |
2014-05-23 |
| Biobase–Qiagen: investment, 201405 acquisition €na by Qiagen |
2014-05-20 |
| Merck (DE)–Sysmex: molecular companion diagnostics, 201405– collab developm + commercialisation blood-based RAS biomarker mutation status test |
2014-05-19 |
| Bayer–Boston Scientific: investment, 201405–201409 acquisition $415m of interventional device business by Boston Scientific |
2014-05-15 |
| Co.don–SEVERAL: investment, 201405 capital increase €5m 2.6m new shares €1.9/share |
2014-05-15 |
| Thermo Fisher–Evans Analytical: ionisation technology, 201405– collab developm pulsed ion source technology for glow discharge MS |
2014-05-14 |
| Locate Therapeutics–Heraeus: investment, 201405 undisclosed investment €na by Heraeus |
2014-05-09 |
| Affymetrix–Danaher: lab automation, –201405 collab product integration fully automated ViewRNA eZ Assays on Leica BOND RX staining platform |
2014-05-08 |
| ImaginAb–SEVERAL: investment, 201405 financing round Series B $21m led by Mérieux Développement |
2014-05-08 |
| Lophius–SEVERAL: investment, 201405 financing round €2m VRD GmbH + S-Refit + another existing investor |
2014-05-08 |
| Eternygen–Evotec: drug discovery services, 201405– colllab identification + developm small-molecule inhibitors agianst target in metoblic disease |
2014-05-06 |
| Anokion–SEVERAL: investment, 201405 financing round Series A CHF33m ($37.5m) led by Novartis Venture + Novo Ventures + Versant Ventures |
2014-05-05 |
| Bayer–Cenix BioScience: drug target discovery, 201405– supply research service €na RNAi-based techn to identify targets for undisclosed indication |
2014-05-05 |
| Novartis–Ophthotech: pegpleranib, 201405– excl license + commercialisation agreem outside of US |
2014-05-01 |
| OptiBioCat project–EU (govt): grant, 201405– FP7 grant €7m to develop biocatalysts for cosmetics production |
2014-05-01 |
| Quantapore–SEVERAL: investment, 201405 financing round Series B up to $35m from undisclosed investors |
2014-05-01 |
| SomPharmaceuticals–SEVERAL: investment, 201404 private placement CHF750k Series A |
2014-04-29 |
| AllPure Technologies–Sartorius: investment, 201404– acquisition of majority stake €na by Sartorius Stedim Biotech signed |
2014-04-28 |
| CytoTools–SEVERAL: investment, 201404 capital increase €2.3m of DermaTools Biotech GmbH from mother CytoTools + existing investor |
2014-04-28 |
| Merck (US)–Agenus: antibody cancer drug, 201402– collab + license up to $100m milestones + royalties use of 4-Antibody Retrocyte Display technology |
2014-04-28 |
| Sequana Medical–SEVERAL: investment, 201404 financing round Series C CHF23m ($26.2m) led by LSP with NeoMed remaing largest investor |
2014-04-28 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 27 28 29 ... 54 55 56 
Date![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
